US Stock MarketDetailed Quotes

Neuphoria Therapeutics (NEUP)

Watchlist
  • 4.100
  • +0.060+1.49%
Close Jan 15 16:00 ET
  • 4.100
  • 0.0000.00%
Post 20:01 ET
22.05MMarket Cap-1.02P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neuphoria Therapeutics (NEUP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
Total revenue
0
15.65M
-13.27K
15M
662.72K
0
0
0
0
0
Operating revenue
--0
--15.65M
---13.27K
--15M
--662.72K
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
58.44%5.65M
-7.41%16.48M
6.30%5.82M
26.50%3.03M
-8.93%4.06M
-34.75%3.57M
-17.45%17.8M
5.48M
2.39M
4.46M
Selling and administrative expenses
12.01%1.87M
-8.27%7.77M
-13.06%2.07M
17.68%1.41M
4.42%2.63M
-29.95%1.67M
-4.90%8.47M
--2.38M
--1.2M
--2.52M
-General and administrative expense
12.01%1.87M
-8.27%7.77M
-13.06%2.07M
17.68%1.41M
4.42%2.63M
-29.95%1.67M
-4.90%8.47M
--2.38M
--1.2M
--2.52M
Research and development costs
99.15%3.79M
-4.38%9.01M
21.16%3.75M
34.83%1.62M
-14.64%1.74M
-38.45%1.9M
-27.95%9.42M
--3.1M
--1.2M
--2.03M
Other operating expenses
----
-214.98%-299.91K
570.51%1.1K
2,028.78%5.23K
-223.34%-306.23K
----
77.48%-95.22K
---234
---271
---94.71K
Operating profit
-58.44%-5.65M
95.34%-829.19K
-6.54%-5.84M
600.13%11.97M
23.80%-3.4M
34.75%-3.57M
17.45%-17.8M
-5.48M
-2.39M
-4.46M
Net non-operating interest income expense
293.38%142K
-24.35%166.5K
230.63%87.05K
-75.78%12.74K
-44.05%30.62K
-58.24%36.1K
-31.89%220.1K
26.33K
52.62K
54.72K
Non-operating interest income
293.38%142K
-24.35%166.5K
230.63%87.05K
-75.78%12.74K
-44.05%30.62K
-58.24%36.1K
-31.89%220.1K
--26.33K
--52.62K
--54.72K
Other net income (expense)
-270.76%-4.43M
-108.78%-175.31K
-224.58%-3.4M
-91.08%-803.73K
872.37%1.43M
2,156.10%2.59M
803.93%2M
2.73M
-420.62K
-185.78K
Gain on sale of security
77.95%-61.74K
-108.78%-175.31K
-224.58%-3.4M
-91.08%-803.73K
872.37%1.43M
-121.91%-280.04K
803.93%2M
--2.73M
---420.62K
---185.78K
Other non- operating income (expenses)
-251.98%-4.37M
----
----
----
----
--2.87M
----
----
----
----
Income before tax
-961.00%-9.94M
94.62%-838K
-236.27%-9.15M
504.85%11.18M
57.91%-1.93M
82.99%-936.97K
27.61%-15.58M
-2.72M
-2.76M
-4.59M
Income tax
73.68%-34.79K
-436.38%-468.37K
-681.46%-266.6K
-595.55%-81.19K
133.36%11.61K
-279.92%-132.19K
37.26%-87.32K
-34.12K
16.38K
-34.79K
Net income
-1,130.95%-9.91M
97.61%-369.63K
-230.61%-8.88M
505.38%11.26M
57.33%-1.94M
85.29%-804.79K
27.54%-15.49M
-2.69M
-2.78M
-4.55M
Net income continuous Operations
-1,130.95%-9.91M
97.61%-369.63K
-230.61%-8.88M
505.38%11.26M
57.33%-1.94M
85.29%-804.79K
27.54%-15.49M
---2.69M
---2.78M
---4.55M
Minority interest income
Net income attributable to the parent company
-1,130.95%-9.91M
97.61%-369.63K
-230.61%-8.88M
505.38%11.26M
57.33%-1.94M
85.29%-804.79K
27.54%-15.49M
-2.69M
-2.78M
-4.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1,130.95%-9.91M
97.61%-369.63K
-230.61%-8.88M
505.38%11.26M
57.33%-1.94M
85.29%-804.79K
27.54%-15.49M
-2.69M
-2.78M
-4.55M
Basic earnings per share
-611.29%-4.41
98.76%-0.23
-69.30%-5.79
331.45%6.55
76.84%-1.23
-1,312.37%-0.62
-7,658.33%-18.62
-3.42
-2.83
-5.31
Diluted earnings per share
-611.29%-4.41
98.76%-0.23
-69.30%-5.79
331.45%6.55
76.84%-1.23
-1,312.37%-0.62
-7,658.33%-18.62
-3.42
-2.83
-5.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023
Total revenue 015.65M-13.27K15M662.72K00000
Operating revenue --0--15.65M---13.27K--15M--662.72K--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 58.44%5.65M-7.41%16.48M6.30%5.82M26.50%3.03M-8.93%4.06M-34.75%3.57M-17.45%17.8M5.48M2.39M4.46M
Selling and administrative expenses 12.01%1.87M-8.27%7.77M-13.06%2.07M17.68%1.41M4.42%2.63M-29.95%1.67M-4.90%8.47M--2.38M--1.2M--2.52M
-General and administrative expense 12.01%1.87M-8.27%7.77M-13.06%2.07M17.68%1.41M4.42%2.63M-29.95%1.67M-4.90%8.47M--2.38M--1.2M--2.52M
Research and development costs 99.15%3.79M-4.38%9.01M21.16%3.75M34.83%1.62M-14.64%1.74M-38.45%1.9M-27.95%9.42M--3.1M--1.2M--2.03M
Other operating expenses -----214.98%-299.91K570.51%1.1K2,028.78%5.23K-223.34%-306.23K----77.48%-95.22K---234---271---94.71K
Operating profit -58.44%-5.65M95.34%-829.19K-6.54%-5.84M600.13%11.97M23.80%-3.4M34.75%-3.57M17.45%-17.8M-5.48M-2.39M-4.46M
Net non-operating interest income expense 293.38%142K-24.35%166.5K230.63%87.05K-75.78%12.74K-44.05%30.62K-58.24%36.1K-31.89%220.1K26.33K52.62K54.72K
Non-operating interest income 293.38%142K-24.35%166.5K230.63%87.05K-75.78%12.74K-44.05%30.62K-58.24%36.1K-31.89%220.1K--26.33K--52.62K--54.72K
Other net income (expense) -270.76%-4.43M-108.78%-175.31K-224.58%-3.4M-91.08%-803.73K872.37%1.43M2,156.10%2.59M803.93%2M2.73M-420.62K-185.78K
Gain on sale of security 77.95%-61.74K-108.78%-175.31K-224.58%-3.4M-91.08%-803.73K872.37%1.43M-121.91%-280.04K803.93%2M--2.73M---420.62K---185.78K
Other non- operating income (expenses) -251.98%-4.37M------------------2.87M----------------
Income before tax -961.00%-9.94M94.62%-838K-236.27%-9.15M504.85%11.18M57.91%-1.93M82.99%-936.97K27.61%-15.58M-2.72M-2.76M-4.59M
Income tax 73.68%-34.79K-436.38%-468.37K-681.46%-266.6K-595.55%-81.19K133.36%11.61K-279.92%-132.19K37.26%-87.32K-34.12K16.38K-34.79K
Net income -1,130.95%-9.91M97.61%-369.63K-230.61%-8.88M505.38%11.26M57.33%-1.94M85.29%-804.79K27.54%-15.49M-2.69M-2.78M-4.55M
Net income continuous Operations -1,130.95%-9.91M97.61%-369.63K-230.61%-8.88M505.38%11.26M57.33%-1.94M85.29%-804.79K27.54%-15.49M---2.69M---2.78M---4.55M
Minority interest income
Net income attributable to the parent company -1,130.95%-9.91M97.61%-369.63K-230.61%-8.88M505.38%11.26M57.33%-1.94M85.29%-804.79K27.54%-15.49M-2.69M-2.78M-4.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1,130.95%-9.91M97.61%-369.63K-230.61%-8.88M505.38%11.26M57.33%-1.94M85.29%-804.79K27.54%-15.49M-2.69M-2.78M-4.55M
Basic earnings per share -611.29%-4.4198.76%-0.23-69.30%-5.79331.45%6.5576.84%-1.23-1,312.37%-0.62-7,658.33%-18.62-3.42-2.83-5.31
Diluted earnings per share -611.29%-4.4198.76%-0.23-69.30%-5.79331.45%6.5576.84%-1.23-1,312.37%-0.62-7,658.33%-18.62-3.42-2.83-5.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -